Skip to main content
. 2018 Jul 20;11(4):293–300. doi: 10.21053/ceo.2018.00108

Table 2.

Differences in clinical manifestations according to nutritional status

Patient demographics Hypoalbuminemia (serum albumin <3.0 g/dL, n=62) Normoalbuminemia (serum albumin ≥3.0 g/dL, n=73) P-valuea) Underweight (BMI <18.5 kg/m2, n=17) Normal-to-overweight (BMI ≥18.5 kg/m2, n=118) P-valuea)
Age (yr) 67.8±13.3 56.1±15.8 <0.001b) 59.6±20.2 61.7±15.1 0.612
CCI >1 37 (59.7) 36 (49.3) 0.229 8 (47.1) 65 (55.1) 0.535
Clinical & laboratory findings on initial presentation
 Simultaneous mediastinitis 13 (21.0) 6 (8.2) 0.034b) 4 (23.5) 15 (12.7) 0.261
 Necrotizing fasciitis 8 (12.9) 1 (1.4) 0.012b) 0 9 (7.6) 0.602
 Bilateral involvement 17 (27.4) 13 (17.8) 0.181 4 (23.5) 26 (22.0) 1.000
 Extended to >1 cervical level 45 (72.6) 40 (54.8) 0.033b) 10 (58.8) 75 (63.6) 0.705
 WBC (×106/L) 10,600.3±7,550.6 9,164.5±6,872.5 0.445 12,727.2±4,784.0 11,943.8±4,402.0 0.499
 CRP (mg/dL) 22.4±9.8 17.4±8.8 0.002b) 18.5±11.4 19.9±9.3 0.578
Clinical outcome and response to the treatment
 Length of hospitalization (day) 25.0±14.6 14.6±10.9 <0.001b) 21.1±18.7 19.1±12.1 0.584
 No. of surgical drainage 1.8±1.2 1.6±0.8 0.248 1.8±0.9 1.7±1.0 0.716
 No. of dead patients 4 (6.5) 7 (9.6) 0.548 1 (5.9) 10 (8.5) 1.000
 1-Week follow-up CRP (mg/dL) 7.2±5.2 4.4±4.6 0.001b) 6.3±6.2 5.6±4.9 0.547
 Time interval for 50% decrease of initial CRP (day) 6.4±4.2 5.0±3.0 0.029b) 6.1±3.9 5.5±3.6 0.669b)

Values are presented as mean±standard deviation or number (%).

BMI, body mass index; CCI, Charlson comorbidity index; WBC, white blood cell; CRP, C-reactive protein.

a)

Values for or proportion of patients in each clinical factor between the two groups (hypoalbuminemia vs. normoalbuminemia group and underweight vs. normal-to-overweight group) upon initial presentation were compared using Student t-test, chi-squared test, and Fisher exact test.

b)

P-value <0.05.